Curis to Present at the Jefferies 2015 Healthcare Conference
May 27, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., May 27, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Announces Presentations of CUDC-907 and Erivedge(R) Clinical Data at 2015 ASCO Annual Meeting
May 20, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., May 20, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Reports First Quarter 2015 Financial Results
May 07, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of...
Curis to Release First Quarter 2015 Financial Results and Hold Conference Call on May 7, 2015
April 30, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Presents Preclinical Data on CUDC-427 at AACR Annual Meeting
April 22, 2015 08:05 ET
|
Curis, Inc.
LEXINGTON, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Announces Presentation of Data From CUDC-427 and IRAK-4 Programs at AACR Annual Meeting
April 14, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., April 14, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Announces Orphan Drug Designation for CUDC-907 in Diffuse Large B-Cell Lymphoma
April 06, 2015 07:00 ET
|
Curis, Inc.
LEXINGTON, Mass., April 6, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis to Present at the 27th Annual Roth Conference
March 03, 2015 16:00 ET
|
Curis, Inc.
LEXINGTON, Mass., March 3, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...
Curis Announces Closing of Public Offering of Common Stock
March 02, 2015 16:00 ET
|
Curis, Inc.
LEXINGTON, Mass., March 2, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), announced today the closing of its previously announced public offering of common stock. Curis sold 25,090,908 shares of...
Curis to Present at the Cowen and Company 35th Annual Health Care Conference
February 26, 2015 16:00 ET
|
Curis, Inc.
LEXINGTON, Mass., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment...